Navigation Links
FASEB joins President Obama in urging Congress to sustain investments in research and innovation
Date:2/13/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) enthusiastically supports President Barack Obama's call to Congress to maintain key federal investments in research and development as outlined in his State of the Union address last night. "Once again we sincerely appreciate the President's emphasis on scientific innovation and his willingness to make funding for research a national priority. We should not sacrifice our commitment to the research that has dramatically improved the quality of life for Americans and people around the world," stated Judith S. Bond, PhD, FASEB President.

FASEB also praised the President's emphasis on increasing investments in science and innovation. President Obama said, "Now is not the time to gut these job-creating investments in science and innovation. Now is the time to reach a level of research and development not seen since the height of the Space Race." In addition, the President noted that the automatic spending cuts known as sequestration would devastate priorities like education, energy, and medical research. "We will continue our advocacy efforts to urge Congress to sustain federal funding for the National Institutes of Health, the National Science Foundation, and the other research agencies," said Dr. Bond. Scientists and researchers from around the country have already sent nearly 20,000 emails to Capitol Hill in response to e-action alerts issued by FASEB. "I urge everyone in the scientific community to contact their members of Congress today and forward the FASEB alert to their colleagues," added the FASEB President.


'/>"/>

Contact: Lawrence Green
lgreen@faseb.org
301-634-7335
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
2. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
3. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
4. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
5. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
6. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
7. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
8. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
9. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
10. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
11. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... ... January 17, 2017 , ... LGC ... to its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates ... Each VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” method ...
(Date:1/17/2017)... 17, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... 2016 sales and earnings conference call will be broadcast ... at 8 a.m. Eastern Time.  A news release detailing ... at 7:30 a.m. Eastern Time the morning of the ... be accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:1/17/2017)... MANHASSET, N.Y. , Jan. 17, 2017 /PRNewswire-USNewswire/ ... to speed the advance of precision cancer research. ... State,s largest health care provider, Northwell ... each year. Indivumed, GmbH is a ... individualize anti-cancer medical therapies. Together they will greatly ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, a ... announced a collaboration with the Heidelberg University Hospital and the German Cancer Research ... following the company’s successful launch of its CATS (Capture and Amplification by ...
Breaking Biology Technology: